4D Molecular Therapeutics, Inc. (FDMT)
Market Cap | 948.76M |
Revenue (ttm) | 20.45M |
Net Income (ttm) | -104.56M |
Shares Out | 51.70M |
EPS (ttm) | -2.44 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 680,153 |
Open | 18.80 |
Previous Close | 18.52 |
Day's Range | 18.22 - 19.33 |
52-Week Range | 9.44 - 36.25 |
Beta | 2.82 |
Analysts | Strong Buy |
Price Target | 46.25 (+152.04%) |
Earnings Date | Aug 7, 2024 |
About FDMT
4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company, develops genetic medicines using its therapeutic vector evolution platform in the Netherland and the United States. The company develops a portfolio of genetic medicine product candidates focuses in three therapeutic areas for ophthalmology, cardiology, and pulmonology. Its product pipeline includes 4D-150, which is in phase 1/2 clinical trial for the treatment of wet age-related macular degeneration; and is in phase 1/2 clinical trial for the treatment of diabetic macul... [Read more]
Financial Performance
In 2023, FDMT's revenue was $20.72 million, an increase of 562.29% compared to the previous year's $3.13 million. Losses were -$100.84 million, -6.19% less than in 2022.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for FDMT stock is "Strong Buy." The 12-month stock price forecast is $46.25, which is an increase of 152.04% from the latest price.
News
4D Molecular Therapeutics, Inc. (FDMT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co...
The Schall Law Firm Invites FDMT Investors To Participate In The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Ther...
Investors who lost money on 4D Molecular Therapeutics, Inc. should contact Levi & Korsinsky about an ongoing investigation - FDMT
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co...
FDMT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Stockholders to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp...
An Investigation Has Commenced on Behalf of 4D Molecular Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your FDMT Losses.
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co...
4D Molecular Therapeutics, Inc. (FDMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. (“4D...
The Schall Law Firm Invites FDMT Investors To Join The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Ther...
FDMT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of 4D Molecular Therapeutics, Inc. Shareholders Who Lost Money
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co...
FDMT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Stockholders to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp...
Lost Money on 4D Molecular Therapeutics, Inc.(FDMT)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co...
The Schall Law Firm Invites FDMT Investors To Join The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.
LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Ther...
FDMT ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your 4D Molecular Therapeutics, Inc. investment
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co...
FDMT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Shareholders to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp...
4D Molecular Therapeutics, Inc. (FDMT) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co...
The Schall Law Firm Invites FDMT Investors To Participate In The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.
LOS ANGELES, CA / ACCESSWIRE / July 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Ther...
ATTENTION 4D Molecular Therapeutics, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co...
4D Molecular Therapeutics Being Investigated on Behalf of 4D Molecular Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co...
FDMT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Shareholders to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp...
FDMT Investors Have Opportunity to Join 4D Molecular Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
LOS ANGELES , July 22, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Therape...
FDMT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Shareholders to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / July 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp...
4D Molecular Therapeutics, Inc. (FDMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)---- $FDMT #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ...
FDMT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Investors to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp...
FDMT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Investors to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / July 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp...
4D Molecular Therapeutics Inc Stakeholders Are Welcomed By The Schall Law Firm To Participate In The Securities Fraud Probe
LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Ther...
FDMT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Investors to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / July 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp...